# ClinicalTrials.gov record NCT04561245

> PeptideScanner retained ClinicalTrials.gov record NCT04561245 at 2026-07-30T18:26:04.261Z. Its registry update date was 2025-06-24, and PeptideScanner's reviewed identity mapping was pemvidutide.

- Evidence object: `story:clinicaltrials-gov-nct04561245-pemvidutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2025-06-24
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04561245-pemvidutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04561245-pemvidutide-v1.json
- Content SHA-256: `8192d0019213636bad535d1c25e6fdff1b8f395bbb11076995f20033a6567801`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT04561245 ([`ctg-observation-nct04561245-2025-06-24-1e6939e41736`](#source-ctg-observation-nct04561245-2025-06-24-1e6939e41736))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04561245 at 2026-07-30T18:26:04.261Z. Its registry update date was 2025-06-24, and PeptideScanner's reviewed identity mapping was pemvidutide. ([`ctg-observation-nct04561245-2025-06-24-1e6939e41736`](#source-ctg-observation-nct04561245-2025-06-24-1e6939e41736))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04561245 at 2026-07-30T18:26:04.261Z. Its registry update date was 2025-06-24, and PeptideScanner's reviewed identity mapping was pemvidutide. ([`ctg-observation-nct04561245-2025-06-24-1e6939e41736`](#source-ctg-observation-nct04561245-2025-06-24-1e6939e41736))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04561245-2025-06-24-1e6939e41736`](#source-ctg-observation-nct04561245-2025-06-24-1e6939e41736))

## Sources

<a id="source-ctg-observation-nct04561245-2025-06-24-1e6939e41736"></a>
- **ClinicalTrials.gov record NCT04561245 · retained source version 2025-06-24:1e6939e417365c1394244d943ca47339571423ba9976eb3f9522e85c0bff80da** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04561245) (`ctg-observation-nct04561245-2025-06-24-1e6939e41736`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04561245." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04561245-pemvidutide-v1.json SHA-256: 8192d0019213636bad535d1c25e6fdff1b8f395bbb11076995f20033a6567801.